Help-
Working together to make a difference
Find Us Here
Recent Additions 2009
Dec
Nov
Chronic Cerebrospinal Venous Insufficiency -
Sept
Multiple Sclerosis and Whole Body Vibration Technology (WBVT)
Seasonal Flu shot may increase H1N1 risk -
BT Telephone Scam Warning (takes you to BT web site)
Are Bacteria the Root Cause of MS and Other "Auto-
Lyme Disease Epidemic Causing Healthcare Crisis -
Blood Test May Predict Course Of MS -
Dirucotide Does Not Meet Primary Endpoint In Phase III MAESTRO-
Researchers at Aurora St. Luke's Medical Center in Milwaukee report that plasma exchange therapy or PLEX dramatically improves the health of multiple sclerosis patients who fail to respond to conventional therapies. Newscom (off site) Aurora (off site)
Acorda Therapeutics Reports Date of FDA Advisory Committee Review of Fampridine-
A Natural Break-
The Multiple Sclerosis (MS) Market Has Total Global Revenues of Over $6bn in 2008. It Will Exceed $9bn During the Second Half of Next Decade.
Source -
Leading causes of paralysis in the US
August
Assisted Suicide (Don't book a ticket to Dignitas just yet) Times Online
LDN Awareness week 19th -
July 2009
A patent for 'The Treatment of HIV' has been added to the AIMSPRO IP portfolio, having an effective date of 31st March 2009. Aimspro
June
May
The Australian Government, through the Department of Health and Ageing, has designated AIMSPRO as an orphan drug for use in the treatment of amyotrophic lateral sclerosis with effect from 15 May 2009. Aimspro Orphan Status
April
Oral MS drug, Cladribine, appears effective, but cancer cases raise concerns
Anti-
Low Dose Naltrexone (LDN) appears to relieve Fibromyalgia Pain
March
Dangerously high levels of undeclared pharmaceuticals have been discovered in a supposed ‘Herbal Viagra’ being sold in many Traditional Chinese Medicine (TCM) stores in the United Kingdom.MHRA Alert
MS Neurologists Skittish On Side Effects -
Scleroderma & Aimspro trial -
Feb
Scleroderma & Aimspro trial Sclero.org
Jan
Stem Cell Research Published The Guardian The Lancet
New Death Reported -
Study links Gene Varient and Vitamin D to MS Risk Reuters PloS Genetics
Online Poll result -
“Is the data from clinical trials reliable? French judges probe firms over vaccinations.”
-
“Caregivers and quality of life in the US” -
“What was the Guardian article all about?” -
“Attacking Proventus” -
“In response to the Guardian Article” -
“The Pharmacist who mishandled Aimspro” -
“Misconduct of the overseeing Pharmacist” -
“There really is something going on” -
“AIMSPRO at St.George's Hospital” -
“Alan Osmond travelled to England to be treated with Aimspro” -
“Alan Osmond -
“Consternation within the MS community is being caused by confusion” -
Lyme Disease Ticks Don’t Come Out In The Wash
AIMSPRO® bowel & bladder trial in multiple sclerosis (MS) Trial
A double-